The TGF-beta superfamily member activin A in pulmonary arterial hypertension. Clinical and experimental studies

被引:0
|
作者
Yndestad, A.
Larsen, K. O.
Oie, E.
Ueland, T.
Anfinsen, O. G.
Christensen, G.
Aukrust, P.
Andreassen, A. K.
机构
[1] Univ Oslo, Rikshosp, Internal Med Res Inst, N-0027 Oslo, Norway
[2] Univ Oslo, Ulleval Hosp, Expt Med Res Inst, Oslo, Norway
[3] Univ Oslo, Rikshosp, Inst Surg Res, N-0027 Oslo, Norway
[4] Univ Oslo, Rikshosp, Dept Cardiol, N-0027 Oslo, Norway
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P611
引用
收藏
页码:83 / 83
页数:1
相关论文
共 50 条
  • [41] Microvascular Endothelial Cells Of Pulmonary Arterial Hypertension Patients Are More Sensitive To Bmp9 Stimulation And Activate Both The Bmp And Tgf-Beta Signaling Cascade
    Rol, N.
    Szulcek, R.
    Kurakula, K.
    Pan, X.
    Dickhoff, C.
    Vonk-Noordegraaf, A.
    Goumans, M. T. H.
    Bogaard, H. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [42] Assignment of a new TGF-beta superfamily member, human cartilage-derived morphogenetic protein-1, to chromosome 20q11.2
    Lin, KM
    Thomas, JT
    McBride, OW
    Luyten, FP
    GENOMICS, 1996, 34 (01) : 150 - 151
  • [43] Pulmonary Arterial Hypertension. Clinical manifestations and treatment with sildenafil in children: Literature review and Analysis of 11 cases
    Juarez Olguin, Hugo
    Liquidano Perez, Eduardo
    Roldan Arce, Arturo
    Perez Saldana, Stephanie Rubi
    REVISTA LATINOAMERICANA DE HIPERTENSION, 2015, 10 (01): : 108 - 114
  • [44] Role of biomarkers in evaluation, treatment and clinical studies of pulmonary arterial hypertension
    Hemnes, Anna
    Rothman, Alexander M. K.
    Swift, Andrew J.
    Zisman, Lawrence S.
    PULMONARY CIRCULATION, 2020, 10 (04)
  • [45] TGF-beta Antagonist Antibody 1D11 Blocks Experimental Progressive Pulmonary Fibrosis.
    Maharaj, S.
    Ask, K.
    Moeller, A.
    Wang, L.
    Farkas, L.
    Inman, M.
    Gregory, R.
    Lonning, S.
    Souza, K.
    Gauldie, J.
    Kolb, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [46] Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension
    Machado, RD
    Thomson, JR
    Loyd, JE
    Nichols, WC
    Trembath, RC
    THORAX, 2000, 55 : A23 - A23
  • [47] Diosgenin inhibits TGF-beta 1/Smad signaling and regulates epithelial mesenchymal transition in experimental pulmonary fibrosis
    Dinesh Babu, Vadivel
    Suresh Kumar, Anandasadagopan
    Sudhandiran, Ganapasam
    DRUG AND CHEMICAL TOXICOLOGY, 2022, 45 (03) : 1264 - 1275
  • [48] Pulmonary hemodynamic changes, functional capacity and clinical events in pulmonary arterial hypertension. A meta-analysis of 16 randomized trials
    Savarese, G.
    Musella, F.
    D'Amore, C.
    Cecere, M.
    Losco, T.
    Marciano, C.
    Gargiulo, P.
    Perrone-Filardi, P.
    EUROPEAN HEART JOURNAL, 2012, 33 : 423 - 423
  • [49] Stable isotope metabolomics of pulmonary artery smooth muscle and endothelial cells in pulmonary hypertension and with TGF-beta treatment (vol 10, 413, 2020)
    Hernandez-Saavedra, Daniel
    Sanders, Linda
    Freeman, Scott
    Reisz, Julie A.
    Lee, Michael H.
    Mickael, Claudia
    Kumar, Rahul
    Kassa, Biruk
    Gu, Sue
    Alessandro, Angelo D'
    Stenmark, Kurt R.
    Tuder, Rubin M.
    Graham, Brian B.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [50] EXPERIMENTAL STUDY ON ARTERIAL COMPLIANCE AND URINARY EXCRETION OF TGF-BETA IN A GROUP OF SMALL-FOR-GESTATIONAL-AGE CHILDREN-ADOLESCENTS
    Strambi, M.
    Messa, G. L.
    Berni, S.
    Capitani, S.
    Iacoponi, F.
    Censurato, C.
    Tene, C. Magne
    Fiorica, A.
    Rotelli, E.
    Vittoria, A.
    JOURNAL OF HYPERTENSION, 2010, 28 : E121 - E121